Commercial-stage company developing and selling next-generation neuromodulation technology rapidly treating treatment resistant depression.
Magnus Medical
Neurology
Total Addressable Market
$2 billion+
Red Tree Board Member(s)
Red Tree Board Member
Heath Lukatch, Ph.D. (board chairman)
Red Tree Participation
Co-led Series A, bridge and Series B